DNADX® is a groundbreaking test designed for patients facing advanced breast cancer.
Our proprietary software, used for diagnostic testing, examines the DNA from tumor tissue or circulating tumor DNA (ctDNA) in the blood.
By analyzing distinctive gene patterns, we uncover crucial details that go beyond single gene alterations, offering valuable insights to shape personalized and targeted treatment plans.